Technical Analysis for ATNF - 180 Life Sciences Corp.

Grade Last Price % Change Price Change
F 5.3388 -7.47% -0.43
ATNF closed up 4.15 percent on Monday, September 27, 2021, on 50 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ATNF trend table...

Date Alert Name Type % Chg
Death Cross Bearish -7.47%
Bullish Engulfing Bullish -7.47%
Bollinger Band Squeeze Range Contraction -7.47%
BB Squeeze Started Range Contraction -7.47%
Outside Day Range Expansion -7.47%
180 Bearish Setup Bearish Swing Setup -3.63%
Narrow Range Bar Range Contraction -3.63%
NR7 Range Contraction -3.63%
Pocket Pivot Bullish Swing Setup -8.74%
Doji - Bullish? Reversal -8.74%
Older End-of-Day Signals for ATNF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 27 minutes ago
Fell Below Lower Bollinger Band about 4 hours ago
Fell Below Previous Day's Low about 4 hours ago
Down 5% about 5 hours ago
1.5x Volume Pace about 5 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF, with its lead program in phase 2b/3 clinical trials.
Classification

Sector: Industrials
Industry: Conglomerates
Keywords: Biotechnology Clinical Medicine Immunology Pain Disease Inflammation Inflammatory Disease Inflammatory Diseases Fibrosis Cytokines Tumor Necrosis Factor Animal Physiology Stanford University Human Physiology

Is ATNF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.04
52 Week Low 1.9
Average Volume 797,689
200-Day Moving Average 6.78
50-Day Moving Average 6.75
20-Day Moving Average 6.00
10-Day Moving Average 5.97
Average True Range 0.58
ADX 11.47
+DI 16.89
-DI 19.01
Chandelier Exit (Long, 3 ATRs) 5.17
Chandelier Exit (Short, 3 ATRs) 6.80
Upper Bollinger Bands 6.66
Lower Bollinger Band 5.34
Percent B (%b) 0.33
BandWidth 21.93
MACD Line -0.26
MACD Signal Line -0.29
MACD Histogram 0.0377
Fundamentals Value
Market Cap 104.04 Million
Num Shares 18 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.34
Resistance 3 (R3) 6.30 6.07 6.25
Resistance 2 (R2) 6.07 5.92 6.09 6.22
Resistance 1 (R1) 5.92 5.83 5.99 5.96 6.18
Pivot Point 5.68 5.68 5.72 5.70 5.68
Support 1 (S1) 5.53 5.54 5.61 5.58 5.36
Support 2 (S2) 5.30 5.45 5.32 5.32
Support 3 (S3) 5.15 5.30 5.29
Support 4 (S4) 5.20